(INSP) Inspire Medical Systems - Ratings and Ratios

Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea (OSA). Its flagship product, the Inspire system, utilizes neurostimulation technology to treat moderate to severe OSA by delivering mild hypoglossal nerve stimulation to maintain an open airway during sleep. The system includes an implantable pulse generator, a sensing lead, and a stimulator lead, offering a closed-loop solution that continuously monitors breathing patterns. Founded in 2007 and headquartered in Golden Valley, Minnesota, the company has established itself as a leader in innovative OSA treatment options, addressing a significant unmet need in the sleep health market.

Looking ahead, Inspire Medical Systems stock is expected to show volatility over the next three months, influenced by its technical and fundamental metrics. With a last price of 159.06 and a 20-day SMA of 150.73, the stock is currently above its short-term moving average but below its 50-day (165.05) and 200-day (181.39) SMAs, suggesting potential sideways movement. The ATR of 8.80 indicates moderate volatility. Fundamentally, the companys market cap of $4.425 billion, P/E of 84.78, and forward P/E of 68.97 reflect high valuation and growth expectations. The P/S ratio of 5.51 and RoE of 7.76 suggest strong revenue generation but moderate profitability. Overall, the stock is likely to remain range-bound with potential upside driven by continued adoption of its OSA treatment solutions.